Severe Asthma in a General Population Study: Prevalence and Clinical Characteristics

References

• Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–373. doi:10.1183/09031936.00202013
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Global strategy for asthma management and prevention. Available from: www.ginasthma.org/gina-reports/. Accessed October 13 2020.
   Google Scholar
• Shaw DE, Sousa AR, Fowler SJ, et al. Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort. Eur Respir J. 2015;46(5):1308–1321. doi:10.1183/13993003.00779-2015
   PubMed Web of Science ®Google Scholar
• Aubier M, Thabut G, Fabry-Vendrand C. Characteristics of patients with severe, uncontrolled, eosinophilic asthma enrolled in a French cohort. J Asthma Allergy. 2018;11:217–224. doi:10.2147/JAA.S170866
   Web of Science ®Google Scholar
• Backman H, Jansson SA, Stridsman C, et al. Severe asthma-A population study perspective. Clin Exp Allergy. 2019;49(6):819–828. doi:10.1111/cea.13378
   PubMed Web of Science ®Google Scholar
• von Bulow A, Kriegbaum M, Backer V, Porsbjerg C. The prevalence of severe asthma and low asthma control among Danish adults. J Allergy Clin Immunol Pract. 2014;2(6):759–767. doi:10.1016/j.jaip.2014.05.005
   PubMed Web of Science ®Google Scholar
• Schleich F, Brusselle G, Louis R, et al. Heterogeneity of phenotypes in severe asthmatics. The Belgian Severe Asthma Registry (BSAR). Respir Med. 2014;108(12):1723–1732. doi:10.1016/j.rmed.2014.10.007
   PubMed Web of Science ®Google Scholar
• Mullerova H, Cockle SM, Gunsoy NB, Nelsen LM, Albers FC. Clinical characteristics and burden of illness among adolescent and adult patients with severe asthma by asthma control: the IDEAL study. J Asthma. 2021;58(4):459–470. doi:10.1080/02770903.2019.1708095
   PubMed Web of Science ®Google Scholar
• Antonicelli L, Bucca C, Neri M, et al. Asthma severity and medical resource utilisation. Eur Respir J. 2004;23(5):723–729. doi:10.1183/09031936.04.00004904
   PubMed Web of Science ®Google Scholar
• Zeiger RS, Schatz M, Dalal AA, et al. Utilization and Costs of Severe Uncontrolled Asthma in a Managed-Care Setting. J Allergy Clin Immunol Pract. 2016;4(1):120–9 e3. doi:10.1016/j.jaip.2015.08.003
   PubMed Web of Science ®Google Scholar
• Sadatsafavi M, Lynd L, Marra C, et al. Direct health care costs associated with asthma in British Columbia. Can Respir J. 2010;17(2):74–80. doi:10.1155/2010/361071
   PubMed Web of Science ®Google Scholar
• Hekking PW, Wener RR, Amelink M, Zwinderman AH, Bouvy ML, Bel EH. The prevalence of severe refractory asthma. J Allergy Clin Immunol. 2015;135(4):896–902. doi:10.1016/j.jaci.2014.08.042
   PubMed Web of Science ®Google Scholar
• Varsano S, Segev D, Shitrit D. Severe and non-severe asthma in the community: a large electronic database analysis. Respir Med. 2017;123:131–139. doi:10.1016/j.rmed.2016.12.017
   PubMed Web of Science ®Google Scholar
• Larsson K, Stallberg B, Lisspers K, et al. Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR). Respir Res. 2018;19(1):12. doi:10.1186/s12931-018-0719-x
   PubMed Web of Science ®Google Scholar
• Nagase H, Adachi M, Matsunaga K, et al. Prevalence, disease burden, and treatment reality of patients with severe, uncontrolled asthma in Japan. Allergol Int. 2020;69(1):53–60. doi:10.1016/j.alit.2019.06.003
   PubMed Web of Science ®Google Scholar
• Ryan D, Heatley H, Heaney LG, et al. Potential Severe Asthma Hidden in UK Primary Care. J Allergy Clin Immunol Pract. 2021;9(4):1612–1623 e9. doi:10.1016/j.jaip.2020.11.053
   Web of Science ®Google Scholar
• Porsbjerg C, Ulrik C, Skjold T, et al. Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults. Eur Clin Respir J. 2018;5(1):1440868. doi:10.1080/20018525.2018.1440868
   PubMed Web of Science ®Google Scholar
• Ekerljung L, Bossios A, Lotvall J, et al. Multi-symptom asthma as an indication of disease severity in epidemiology. Eur Respir J. 2011;38(4):825–832. doi:10.1183/09031936.00143710
   PubMed Web of Science ®Google Scholar
• Lotvall J, Ekerljung L, Ronmark EP, et al. West Sweden Asthma Study: prevalence trends over the last 18 years argues no recent increase in asthma. Respir Res. 2009;10:94. doi:10.1186/1465-9921-10-94
   PubMed Web of Science ®Google Scholar
• Nwaru BI, Ekerljung L, Radinger M, et al. Cohort profile: the West Sweden Asthma Study (WSAS): a multidisciplinary population-based longitudinal study of asthma, allergy and respiratory conditions in adults. BMJ Open. 2019;9(6):e027808. doi:10.1136/bmjopen-2018-027808
   PubMed Web of Science ®Google Scholar
• Rönmark EP, Ekerljung L, Lötvall J, Torén K, Rönmark E, Lundbäck B. Large scale questionnaire survey on respiratory health in Sweden: effects of late- and non-response. Respir Med. 2009;103(12):1807–1815. doi:10.1016/j.rmed.2009.07.014
   PubMed Web of Science ®Google Scholar
• World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Available from: https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/. Accessed August 18 2021.
   Google Scholar
• Global Initiative for Asthma. Global strategy for asthma management and prevention. Available from: www.ginasthma.org/archived-reports/. Accessed October 13 2020.
   Google Scholar
• Kosinski MBM, Turner-Bowker DM, Fortin EW. Asthma Control Test™: A User’s Guide. QualityMetric Incorporated; 2004.
   Google Scholar
• Ilmarinen P, Tuomisto LE, Niemela O, Kankaanranta H. Prevalence of Patients Eligible for Anti-IL-5 Treatment in a Cohort of Adult-Onset Asthma. J Allergy Clin Immunol Pract. 2019;7(1):165–174 e4. doi:10.1016/j.jaip.2018.05.032
   PubMed Web of Science ®Google Scholar
• Csoma Z, Gal Z, Gezsi A, Herjavecz I, Szalai C. Prevalence and characterization of severe asthma in Hungary. Sci Rep. 2020;10(1):9274. doi:10.1038/s41598-020-66445-4
   PubMed Web of Science ®Google Scholar
• Wang E, Wechsler ME, Tran TN, et al. Characterization of Severe Asthma Worldwide: data From the International Severe Asthma Registry. Chest. 2020;157(4):790–804. doi:10.1016/j.chest.2019.10.053
   PubMed Web of Science ®Google Scholar
• Mincheva R, Ekerljung L, Bossios A, Lundback B, Lotvall J. High prevalence of severe asthma in a large random population study. J Allergy Clin Immunol. 2018;141(6):2256–2264 e2. doi:10.1016/j.jaci.2017.07.047
   PubMed Web of Science ®Google Scholar
• Bidad N, Barnes N, Griffiths C, Horne R. Understanding patients’ perceptions of asthma control: a qualitative study. Eur Respir J. 2018;51(6):1701346. doi:10.1183/13993003.01346-2017
   PubMed Web of Science ®Google Scholar
• Foster JM, McDonald VM, Guo M, Reddel HK. “I have lost in every facet of my life”: the hidden burden of severe asthma. Eur Respir J. 2017;50(3):1700765. doi:10.1183/13993003.00765-2017
   PubMed Web of Science ®Google Scholar
• Takala J, Ilmarinen P, Tuomisto LE, Vahatalo I, Niemela O, Kankaanranta H. Planned primary health care asthma contacts during 12-year follow-up after Finnish National Asthma Programme: focus on spirometry. NPJ Prim Care Respir Med. 2020;30(1):8. doi:10.1038/s41533-020-0166-2
   PubMed Web of Science ®Google Scholar
• Stridsman C, Axelsson M, Warm K, Backman H. Uncontrolled asthma occurs in all GINA treatment steps and is associated with worse physical health - A report from the OLIN adult asthma cohort. J Asthma. 2021;58(5):586–595. doi:10.1080/02770903.2020.1713150
   PubMed Web of Science ®Google Scholar
• Axelsson M, Ekerljung L, Lundback B. The Significance of Asthma Follow-Up Consultations for Adherence to Asthma Medication, Asthma Medication Beliefs, and Asthma Control. Nurs Res Pract. 2015;2015:139070.
   PubMedGoogle Scholar
• van Bragt J, Adcock IM, Bel EHD, et al. Characteristics and treatment regimens across ERS SHARP severe asthma registries. Eur Respir J. 2020;55(1):urn:issn:0903–1936. doi:10.1183/13993003.01163-2019
   Web of Science ®Google Scholar
• Kankaanranta H, Lahdensuo A, Moilanen E, Barnes PJ. Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive review. Respir Res. 2004;5(1):17. doi:10.1186/1465-9921-5-17
   PubMed Web of Science ®Google Scholar
• Kankaanranta H, Kauppi P, Tuomisto LE, Ilmarinen P. Emerging Comorbidities in Adult Asthma: risks, Clinical Associations, and Mechanisms. Mediators Inflamm. 2016;2016:3690628. doi:10.1155/2016/3690628
   PubMed Web of Science ®Google Scholar
• Ekerljung L, Mincheva R, Hagstad S, et al. Prevalence, clinical characteristics and morbidity of the Asthma-COPD overlap in a general population sample. J Asthma. 2018;55(5):461–469. doi:10.1080/02770903.2017.1339799
   PubMed Web of Science ®Google Scholar
• von Bulow A, Backer V, Bodtger U, et al. Differentiation of adult severe asthma from difficult-to-treat asthma - Outcomes of a systematic assessment protocol. Respir Med. 2018;145:41–47. doi:10.1016/j.rmed.2018.10.020
   Web of Science ®Google Scholar